Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.450
+0.090 (3.81%)
At close: Mar 10, 2026
-44.57%
Market Cap 1.46B
Revenue (ttm) n/a
Net Income (ttm) -244.91M
Shares Out 617.50M
EPS (ttm) -0.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 946,414
Average Volume 255,728
Open 2.320
Previous Close 2.360
Day's Range 2.300 - 2.450
52-Week Range 2.310 - 5.830
Beta 0.57
RSI 43.57
Earnings Date Mar 27, 2026

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that is in Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 173
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.